Susquehanna International »

Inhibrx Biosciences shares owned by Susquehanna International

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Susquehanna International

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 149k 15.66
2024-06-30 $2.3M 159k 14.17

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Costco Wholesale Corporation (COST)
Advanced Micro Devices (AMD)
Netflix (NFLX)

View all positions for Susquehanna International

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Geode Capital Management
Morgan Stanley
Caption Management
Kennedy Capital Management
Arrowpoint Asset Management
Susquehanna International
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences